Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity

The Lancet

Volumn 339, Issue 8809, 1992, Pages 1570-1571

  Burnet, N G ^a   Wurm, R ^a   Yarnold, J R ^a   Peacock, J H ^a   Nyman, J ^b   Turesson, I ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; FIBROBLAST; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

BREAST NEOPLASMS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; HUMAN; PREDICTIVE VALUE OF TESTS; RADIATION TOLERANCE; SKIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026708350     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)91833-T     Document Type: Article

References (10)

1. Some clinical aspects of radiobiology
2. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation and telangiectasia after 3 and 5 years' follow-up
3. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships
4. Individual variation and dose dependency in the progression rate of skin telangiectasia
5. Optimisation of uncomplicated control for head and neck tumours
6. 25th Paterson Symposium—is there a future for radiosensitivity testing?
7. 125I implantation
8. The radioresponsiveness of human tumours and the initial slope of the survival curve
9. Correlation between PLD repair capacity and the survival curve of human fibroblasts in exponential growth phase: analysis in terms of several parameters
10. Cellular sensitivity to low dose-rate irradiation focuses the problem of tumour radioresistance